无机纳米颗粒在癌症治疗中的研究进展

Abstract
Figure/Table
References
Related Citation (5)

Download:

Full Text ( PDF ) (2550KB)
Export: BibTeX | EndNote (RIS)

Abstract Nanoparticles plays an important role in cancer therapy. In recent years, Nanoparticles have been studied in a number of areas, including drug delivery, vaccine development, antimicrobial, diagnostic, cancer treatment and imaging tools. Nanoparticles are divided into organic nanoparticles and inorganic nanoparticles. Inorganic nanoparticles are widely concerned because of their unique materials, size-dependent physical-chemical properties and special optical/electromagnetic properties, which are not possessed by organic nanoparticles. In cancer therapy, the choice of appropriate method of inorganic nanoparticles and collocation will bring better results for treatment.

Key words： cancer therapy inorganic nanoparticles nanomedicine

Published: 16 July 2021

CLC number:

TB34

Fund:Independent Innovation Projects of Postgraduates of Central South University (2020zzts896).

About author:: Xin Wu graduated from University of South China in June 2019 with a bachelor's degree in clinical medicine. He is a postgraduate student of The Third Xiangya Hospital of Central South University,conducting research under the guidance of professor Jianlong Wang and Jian Li.The main research field is the application of nanomaterials in cancer therapy. He presided over independent innovation projects of postgraduates of Central South University.Jianlong Wang, MD, chief physician, supervisor of master's degree. Deputy Director of Spinal minimally invasive Research Center, Central South University. Vice president of the first Spinal Health Branch of Hunan Health Service Association. Member of the Ninth Professional Committee of Orthopaedics of Hunan Medical Association. Member of minimally invasive Spinal surgery Group of Spinal and Spinal Cord Professional Committee of Chinese Rehabilitation Medical Association.Member of Spine Branch of Orthopaedic Committee of China Medical Education Association. Member of the Spinal infection Education working Group of the Spinal Branch of the Orthopaedic Committee of China Medical Education Association. Member of Spinal and Spinal Cord Professional Committee of Hunan Rehabilitation Medical Association. Member of Osteoporosis Professional Committee of Hunan Rehabilitation Medical Association. The first member of the Professional Committee of Bone repair Materials and Instruments of Hunan Biomaterials Society. He served as Deputy Director of Orthopaedics in Xiangya third Hospital from 2013 to 2020. He has presided over and undertaken more than 10 scientific research projects at all levels, including 3 by the Department of Science and Technology of Hunan Province and 2 by the Natural Science Foundation of Hunan Province. He has published more than 30 professional papers, edited and edited 2 monographs, and studied spinal surgery at Oregon University of Health and Technology in the United States.Jian Li received his M.M. degree and Ph.D. degree in Clinical Laboratory Diagnostics from the third Xiangya hospital, Central South University (CSU) in Sep. 2013—Jun. 2019. He was appointed to the faculty upon graduation, and is currently an assistant research fellow of the CSU. He has published more than 10 journal papers as the first author or corresponding author, applied 3 national invention patents and 1 of them were autho-rized. His research interests focus on the application of new biomimetic nanomedicine system in tumor diagnosis and treatment, immunotherapy for Alzheimer's disease. He presided over youth projects of National Natural Science Foundation of China, changsha Natural Science Foundation, independent innovation projects of postgraduates of Central South University, etc.

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Xin
	ZENG lisheng
	WANG Jianlong
	LI Jian

Cite this article:

WU Xin,ZENG lisheng,WANG Jianlong, et al. Research Progress of Inorganic Nanoparticles in Cancer Therapy[J]. Materials Reports, 2021, 35(Z1): 87-93.

URL:

http://www.mater-rep.com/EN/ OR http://www.mater-rep.com/EN/Y2021/V35/IZ1/87

1 Molassiotis A, Cheng H L, Leung K T, et al.Brain and Behavior,2019,9(6),e01312.
2 Zhang J, Du Q, Song X, et al.Theranostics,2020,10(6),2621.
3 Bor G, Mat Azmi I D, Yaghmur A.Therapeutic Delivery,2019,10(2),113.
4 Ghilli M, Carretta E, Filippo F D, et al.European Journal of Cancer Care: the Official Journal of the European Oncology Nursing Society, 2017,26(4),51.
5 Bregoli L, Movia D, Gavigan-Imedio J D, et al.Nanomedicine : Nanotechnology, Biology, and Medicine,2016,12(1),81.
6 Lambert E, Gorantla V S, Janjic J M.Nanomedicine (London, England),2019,14(20),2697.
7 Xu M, Liu J, Xu X, et al.Materials (Basel, Switzerland),2018,11(10),81.
8 Li J, Huang X Y, Huang R, et al.CARBON,2019,132(146),660.
9 Heuer-Jungemann A, Feliu N, Bakaimi I, et al.Chemical Reviews,2019,119(8),4819.
10 Bayda S, Hadla M, Palazzolo S, et al.Current Medicinal Chemistry,2018,25(34),4269.
11 Bharti S, Kaur G, Jain S, et al.Journal of Drug Targeting,2019,27(8),813.
12 Vines J B, Yoon J H, Ryu N E, et al.Frontiers in Chemistry,2019,7(167),121.
13 Cherukula K, Manickavasagam Lekshmi K, Uthaman S, et al.Nanomaterials (Basel, Switzerland),2016,6(4),76.
14 Eom K, Byun K M, Jun S B, et al.Biophysical Journal,2018,115(8),1481.
15 Khunsuk P O, Chawalitpong S, Sawutdeechaikul P, et al.Molecular Pharmaceutics,2018,15(1),164.
16 Mayle K M, Dern K R, Wong V K, et al.SLAS Technology,2017,22(1),18.
17 Xu X, Chong Y, Liu X, et al.Acta Biomater,2019,56(84),328.
18 Loiseau A, Asila V, Boitel-Aullen G, et al.Biosensors,2019,9(2),78.
19 Verry C, Sancey L, Dufort S, et al.BMJ Open,2019,9(2),e023591.
20 US National Library of Medicine. ClinicalTrials.gov.[2019.01.28]https://clinicaltrials.gov/ct2/show/NCT03818386?term.
21 Verry C, Porcel E, Chargari C, et al.Cancer Radiother,2019,23(8),917.
22 Khalladi N and Thariat J.Bull Cancer,2019,106(12),1070.
23 Xie L, Jin W, Chen H, et al.J Biomed Nanotechnol,2019,15(2),215.
24 Carvalho S M, Leonel A G, Mansur A A P, et al.Biomater Sci,2019,7(5),2102.
25 Pang C, Brunelli A, Zhu C, et al.Nanotoxicology,2016,10(2),129.
26 Wilhelm S, Kaiser M, Wurth C, et al.Nanoscale,2015,7(4),1403.
27 Yang K, Wang C L, Ding S, et al. Material Reports,2019,33(5),1475.
28 Mahajan S, Patharkar A, Kuche K, et al. International Journal of Pharmaceutics,2018,548(1),540.
29 Yoo S, Hou J, Yi W, et al.Scientific Reports,2017,7(1),1071.
30 Li Y and Cao J.Science China. Life Sciences,2018,61(11),1333.
31 Mohajeri M, Behnam B and Sahebkar A.Journal of Cellular Physiology,2018,234(1),298.
32 Lin M S, Chen R T, Yu N Y, et al.Colloids and Surfaces B: Biointerfa-ces,2017,159,613.
33 Mauro N, Scialabba C, Agnello S, et al.Materials Science & Engineering: C, Materials for Biological Applications,2020,9(107),110201.
34 Tu Z, Wycisk V, Cheng C, et al.Nanoscale,2017,9(47) ,18931.
35 Lei W, Liu G, Zhang J, et al.Chemical Society Reviews,2017,46(12),3492.
36 Qin L, Jiang S, He H, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society,2020,13(318),50.
37 Cheng C A, Deng T, Lin F C, et al.Theranostics,2019,9(11),3341.
38 Martinez-Carmona M, Lozano D, Colilla M, et al.Acta Biomater,2018,65,393.
39 Senapati S, Thakur R, Verma S P, et al.J Control Release,2016,53(224),186.
40 Zhang L X, Xie X X, Liu D Q, et al.Biomaterials,2018,13(174),54.
41 Mosquera J, García I and Liz-Marzán L M.Accounts of chemical Research,2018,51(9),2305.
42 Banerjee A, Qi J, Gogoi R, et al.Journal of controlled release : official Journal of the Controlled Release Society,2016,13(238),176.
43 Chen X, Tieleman D P and Liang Q.Nanoscale,2018,10(5),2481.
44 Sallem F, Boudon J, Heintz O, et al.Dalton Transactions (Cambridge, England : 2003),2017,46(44),15386.
45 Xia Q, Zhang Y, Li Z, et al.Acta pharmaceutica Sinica B,2019,9(4),675.
46 Hu C-M J, Fang R H, Wang K-C, et al.Nature,2015,526(7571),118.
47 Wu J, Chen J, Feng Y, et al. Journal of Gene Medicine,2019,21(7),e3088.
48 Mukherjee S, Liang L and Veiseh O.Pharmaceutics,2020,12(2),E147.
49 Hou C, Galvan D D, Meng G, et al.Physical Chemistry Chemical Ph-ysics,2017,19(35),24126.
50 Das P, Colombo M, Prosperi D.Colloids and Surfaces B: Biointerfaces,2019,35(174),42.
51 Ray Chowdhuri A, Bhattacharya D, Sahu S K.Dalton transactions (Cambridge, England : 2003),2016,45(7),2963.
52 Hervault A, Dunn A E, Lim M, et al.Nanoscale,2016,8(24),12152.
53 Libutti S K, Paciotti G F, Byrnes A A, et al.Clinical Cancer Research,2010,16(24),6139.
54 US National Library of Medicine. ClinicalTrials.gov.[2012.05.02]https://clinicaltrials.gov/ct2/show/NCT00436410?term.
55 Nanospectra Biosciences Company(2016).[2016-07-08].www.nanospectra.com.
56 US National Library of Medicine. ClinicalTrials.gov.[2012.05.02]https://clinicaltrials.gov/ct2/show/NCT00848024?term.
57 US National Library of Medicine. ClinicalTrials.gov.[2016.11.03]https://clinicaltrials.gov/ct2/show/NCT01679470?term.
58 Marill J, Anesary N M, Zhang P, et al.Radiat Oncol,2014,9,150,56-67.
59 US National Library of Medicine. ClinicalTrials.gov.[2018.06.04]https://clinicaltrials.gov/ct2/show/NCT02379845?term.
60 US National Library of Medicine. ClinicalTrials.gov.[2020.01.22]https://clinicaltrials.gov/ct2/show/NCT03589339?term.
61 US National Library of Medicine. ClinicalTrials.gov.[2018.06.04]https://clinicaltrials.gov/ct2/show/NCT02805894?term.
62 US National Library of Medicine. ClinicalTrials.gov.[2017.05.10]https://clinicaltrials.gov/ct2/show/NCT01433068?term.
63 US National Library of Medicine. ClinicalTrials.gov.[2020.01.03]https://clinicaltrials.gov/ct2/show/NCT02901483?term.
64 US National Library of Medicine. ClinicalTrials.gov.[2020.01.02]https://clinicaltrials.gov/ct2/show/NCT02465593?term.
65 US National Library of Medicine. ClinicalTrials.gov.[2017.02.03]https://clinicaltrials.gov/ct2/show/NCT02721056?term.
66 US National Library of Medicine. ClinicalTrials.gov.[2017.05.10]https://clinicaltrials.gov/ct2/show/NCT02033447?term.
67 Liu X, Zhang Y, Wang Y, et al.Theranostics,2020,10(8),3793.
68 Rivera Gil P, Huhn D, del Mercato L L, et al.Pharmacological Research,2010,62(2),115.
69 US National Library of Medicine.ClinicalTrials.gov.[2020.04.20https://clinicaltrials.gov/ct2/show/NCT04094077?term.
70 US National Library of Medicine.ClinicalTrials.gov.[2018.07.13https://clinicaltrials.gov/ct2/show/NCT03308604?term.